Clinical and molecular analysis of extended-spectrum β-lactamase- producing enterobacteria in the community setting

Journal of Clinical Microbiology

Volumn 43, Issue 10, 2005, Pages 5048-5054

  Arpin, Corinne ^a   Dubois, Véronique ^a   Maugein, Jeanne ^b   Jullin, Jacqueline ^c   Dutilh, Brigitte ^c   Brochet, Jean Philippe ^c   Larribet, Gilberte ^c   Fischer, Isabelle ^c   Quentin, Claudine ^a  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b HAUT LÉVÊQUE HOSPITAL   (France)

^c Lab d'Analyses Medicales Ruffie A   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; CLAVULANIC ACID; COLISTIN; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; KANAMYCIN; NETILMICIN; OFLOXACIN; PROTEIN SHV 4; PROTEIN TEM 15; PROTEIN TEM 21; PROTEIN TEM 24B; SULFONAMIDE; TETRACYCLINE; TOBRAMYCIN; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY CARE; CONSENSUS SEQUENCE; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE; ENZYME RELEASE; ESCHERICHIA COLI; FEMALE; GENE AMPLIFICATION; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INDWELLING CATHETER; KLEBSIELLA PNEUMONIAE; MALE; MOLECULAR BIOLOGY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; STRAIN IDENTIFICATION;

AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; COMMUNITY-ACQUIRED INFECTIONS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; FEMALE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLASMIDS; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; RISK FACTORS; URINARY TRACT INFECTIONS;

BACTERIA (MICROORGANISMS); ENTEROBACTER AEROGENES; ENTEROBACTERIA; ENTEROBACTERIACEAE; ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 26944502351     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.10.5048-5054.2005     Document Type: Article

References (35)

1. Arpin, C., C. Coze, A. M. Rogues, J. P. Gachie, C. Bebear, and C. Quentin. 1996. Epidemiological study of an outbreak due to multidrug-resistant Enterobacter aerogenes in a medical intensive care unit. J. Clin. Microbiol. 34:2163-2169.
2. Arpin, C., V. Dubois, L. Coulange, C. Andre, I. Fischer, P. Noury, F. Grobost, J. P. Brochet, J. Jullin, B. Dutilh, G. Larribet, I. Lagrange, and C. Quentin. 2003. Extended-spectrum β-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob. Agents Chemother. 47:3506-3514.
3. Arpin, C., A. M. Rogues, S. Kabouche, G. Boulard, C. Quesnel, J. P. Gachie, and C. Quentin. 2000. Prospective survey of colonization and infection caused by SHV-4 producing Klebsiella pneumoniae in a neurosurgical intensive care unit. Epidemiol. Infect. 124:401-408.
4. Bennudes, H., C. Arpin, F. Jude, Z. El-Harrif, C. Bebear, and C. Quentin. 1997. Molecular epidemiology of an outbreak due to extended-spectrum β-lactamase-producing enterobacteria in a French hospital. Eur. J. Clin. Microbiol. Infect. Dis. 16:523-529.
5. Birnboim, H. C., and J. Doly. 1979. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1513-1523.
6. Borer, A., J. Gilad, G. Menashe, N. Peled, K. Riesenberg, and F. Schlaeffer. 2002. Extended-spectrum β-lactamase-producing Enterobacteriaceae strains in community-acquired bacteremia in Southern Israel. Med. Sci. Monit. 8:CR44-CR47.
7. Bosi, C., A. Davin-Regli, C. Bornet, M. Mallea, J. M. Pages, and C. Bollet. 1999. Most Enterobacter aerogenes strains in France belong to a prevalent clone. J. Clin. Microbiol. 37:2165-2169.
8. Colodner, R., W. Rock, B. Chazan, N. Keller, N. Guy, W. Sakran, and R. Raz. 2004. Risk factors for the development of extended-spectrum β-lactamase-producing bacteria in nonhospitalized patients. Eur. J. Clin. Microbiol. Infect. Dis. 23:163-167.
9. Cormican, M., D. Morris, G. Corbett-Feeney, and J. Flynn. 1998. Extended spectrum β-lactamase production and fluoroquinolone resistance in pathogens associated with community acquired urinary tract infection. Diagn. Microbiol. Infect. Dis. 32:317-319.
10. Courvalin, P., F. Goldstein, A. Philippen, and J. Sirot (ed.). 1985. L'antibiogramme. MPC-Vidéom, Paris, France.
11. Daza, R., J. Gutierrez, and G. Piedrola. 2001. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections. Int. J. Antimicrob. Agents. 18:211-215.
12. De Moüy, D., J. D. Cavallo, R. Fahre, E. Garrabe, F. Grobost, M. Amiengaud, R. Labia, et al. 1997. Les entérobactéries isolées d'infections urinaires en pratique de ville: étude AFORCOPIBIO 1995. Med. Mal. Infect. 27:642-645.
13. TEM-21 gene located on a chromosomal interrupted TnA type transposon. Antimicrob. Agents Chemother. 46:3624-3626.
14. Goldstein., F. W., et al. 2000. Antibiotic susceptibility of bacterial strains isolated from patients with community-acquired urinary tract infections in France. Eur. J. Clin. Microbiol. Infect. Dis. 19:112-117.
15. Goussard, S., and P. Courvalin. 1999. Updated sequence information for TEM β-lactamase genes. Antimicrob. Agents Chemother. 43:367-370.
16. Heseltine, P. 2000. Has resistance spread to the community? Clin. Microbiol. Infect. 6:11-16.
17. Hryniewicz, K., K. Szczypa, A. Sulikowska, K. Jankowski, K. Betlejewska, and W. Hryniewicz. 2001. Antibiotic susceptibility of bacterial strains isolated from urinary tract infections in Poland. J. Antimicrob. Chemother. 47:773-780.
18. Jarlier, V., M. H. Nicolas, G. Fournier, and A. Philippen. 1988. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 10:867-878.
19. Lescure, F. X., M. Eveillard, Y. Douadi, and F. Eb. 2001. Community-acquired multiresistant bacteria: an emerging problem? J. Hosp. Infect. 49:149-151.
20. Liu, C. P., N. Y. Wang, C. M. Lee, L. C. Weng, H. K. Tseng, C. W. Liu, C. S. Chiang, and F. Y. Huang. 2004. Nosocomial and community-acquired Enterobacter cloacae bloodstream infection: risk factors for and prevalence of SHV-12 in multiresistant isolates in a medical centre. J. Hosp. Infect. 58:63-77.
21. Mahenthiralingam, E., M. E. Campbell, J. Foster, J. S. Lam, and D. P. Speert. 1996. Random amplified polymorphic DNA typing of Pseudomonas aeruginosa isolates recovered from patients with cystic fibrosis. J. Clin. Microbiol. 34:1129-1135.
22. Millar, M. R., T. R. Walsh, C. J. Linton, S. Zhang, J. P. Leeming, and P. M. Bennett. 2001. Carriage of antibiotic-resistant bacteria by healthy children. J. Antimicrob. Chemother. 47:605-610.
23. Mirelis, B., F. Navarro, E. Miro, R. J. Mesa, P. Coll, and G. Prats. 2003. Community transmission of extended-spectrum β-lactamase. Emerg. Infect. Dis. 9:1024-1025.
24. Munday, C. J., G. M. Whitehead, N. J. Todd, M. Campbell, and P. M. Hawkey. 2004. Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum β-lactamases in York, UK. J. Antimicrob. Chemother. 54:628-633.
25. Neuwirth, C., E. Siebor, A. Pechinot, J. M. Duez, M. Pruneaux, F. Garel, A. Kazmierczak, and R. Labia. 2001. Evidence of in vivo transfer of a plasmid encoding the extended-spectrum β-lactamase TEM-24 and other resistance factors among different members of the family Enterobacteriaceae. J. Clin. Microbiol. 39:1985-1988.
26. Nicolle, L. E., L. J. Strausbaugh, and R. A. Garibaldi. 1996. Infections and antibiotic resistance in nursing homes. Clin. Microbiol. Rev. 9:1-17.
27. Péan, Y., F. W. Goldstein, M. L. Guerrier, F. De Bels, et al. 1999. Sensibilité aux β-lactamines des bactêries isolées en ville et à l'hôpital au cours d'une enquête multicentrique française. Antibiotiques 1:165-170.
28. CTX-M genes. Clin. Infect. Dis. 38:1736-1741.
29. Quentin, C., C. Arpin, V. Dubois, C. Andre, I. Lagrange, I. Fischer, J. P. Brochet, F. Grobost, J. Juliin, B. Dutilh, G. Larribet, and P. Noury. 2004. Antibiotic resistance rates and phenotypes among isolates of Enterobacteriaceae in French extra-hospital practice. Eur. J. Clin. Microbiol. Infect. Dis. 23:185-193.
30. Rodriguez-Baño, J., M. D. Navarro, L. Romero, L. Martinez-Martinez, M. A. Muniain, E. J. Perea, R. Perez-Cano, and A. Pascual. 2004. Epidemiology and clinical features of infections caused by extended-spectrum β-lactamase-producing Escherichia coli in nonhospitalized patients. J. Clin. Microbiol. 42:1089-1094.
31. Tan, B. H., and A. L. Tan. 2002. Community-acquired bacteremia with an ESBL-producing Escherichia coli strain-a case report. Int. J. Infect. Dis. 6:318-319.
32. Tessier, F., C. Arpin, A. Allery, and C. Quentin. 1998. Molecular characterization of a TEM-21 β-lactamase in a clinical isolate of Morganella morganii. Antimicrob. Agents Chemother. 42:2125-2127.
33. Valverde, A., T. M. Coque, M. P. Sanchez-Moreno, A. Rollan, F. Baquero, and R. Canton. 2004. Dramatic increase in prevalence of fecal carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae during non-outbreak situations in Spain. J. Clin. Microbiol. 42:4769-4775.
34. Wiener, J., J. P. Quinn, P. A. Bradford, R. V. Goering, C. Nathan, K. Bush, and R. A. Weinstein. 1999. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes. JAMA 281:517-523.
35. Woodford, N., M. E. Ward, M. E. Kaufmann, J. Turton, E. J. Fagan, D. James, A. P. Johnson, R. Pike, M. Warner, T. Cheasty, A. Pearson, S. Harry, J. B. Leach, A. Loughrey, J. A. Lowes, R. E. Warren, and D. M. Livermore. 2004. Community and hospital spread of Escherichia coli producing CTXM extended-spectrum β-lactamases in the UK. J. Antimicrob. Chemother. 54: 735-743.